Login  |  Register

Novartis to Spin Off Alcon Eye-Care Business - WSJ

Novartis said it would spin off its Alcon eye-care unit, a business analysts think could be valued at more than $20 billion, the latest move by the company’s new chief executive to reshape the Swiss drug giant.

Alexa Traffic